Patents by Inventor Macarena Perán Quesada

Macarena Perán Quesada has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230089740
    Abstract: The present invention relates to compositions, methods, uses and kits for treating cancer. The present invention relates to methods for minimising the progression of cancer in a subject, the method comprising administering to the subject therapeutically effective amounts of chymotrypsinogen and trypsinogen, thereby minimising the progression of cancer in the subject. In particular, the methods provide a means for treating cancer by reducing the number of cancer stem cells in the subject.
    Type: Application
    Filed: June 3, 2022
    Publication date: March 23, 2023
    Applicant: Propanc Pty Ltd
    Inventors: Macarena Perán Quesada, Julian Kenyon, Juan Antonio Marchal Corrales, Maria Angel Garcia Chaves
  • Patent number: 11376313
    Abstract: The present invention relates to compositions, methods, uses and kits for treating cancer. The present invention relates to methods for minimising the progression of cancer in a subject, the method comprising administering to the subject therapeutically effective amounts of chymotrypsinogen and trypsinogen, thereby minimising the progression of cancer in the subject. In particular, the methods provide a means for treating cancer by reducing the number of cancer stem cells in the subject.
    Type: Grant
    Filed: January 27, 2017
    Date of Patent: July 5, 2022
    Assignee: PROPANC PTY LTD
    Inventors: Macarena Perán Quesada, Julian Kenyon, Juan Antonio Marchal Corrales, Maria Angel Garcia Chaves
  • Publication number: 20170226472
    Abstract: The present invention relates to a serum-free conditioned medium that solves the drawbacks mentioned in the prior art, as it does not require prior handling of the cells, and it furthermore allows starting from a large population with no additional cost. This medium favors in vitro proliferation and conservation of the pluripotency potential that allows maintaining a state that is undifferentiated with respect to the subpopulation of cancer stem cells (CSCs) and in turn does not allow survival of the differentiated cells.
    Type: Application
    Filed: August 4, 2015
    Publication date: August 10, 2017
    Applicants: Universidad de Granada, Universidad de Jaén, Servicio Andaluz de Salud
    Inventors: Juan Antonio Marchal Corrales, Gema Jiménez González, Cynthia Morata Tarifa, María Ángel García Chaves, Macarena Perán Quesada